To identify signaling pathways essential for erbb2 mutants to develop HL phenotypes, we performed a targeted small molecule screen to inhibit signaling pathways known to be involved in regulating cardiac hypertrophy20,27–30. The gene discussed is ERBB2; the disease is Hodgkins lymphoma.